The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, a company that's pioneering proton therapy systems for treating tumors ...

One of the new DNA-binding proteins was tested in a medical diagnostic method known as loop-mediated isothermal amplification ...

The Global Biotech Handbook offers opportunities in the biotech sector by detailing regulatory landscapes, clinical trial procedures, intellectual property issues, and market structures across 70 ...

PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on ...

An eczema drug from Nektar Therapeutics maintained skin responses in a one-year study, meeting and in some cases exceeding ...

The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter are often left out.

The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture.

Cliff Greenberg discusses Baron Small Cap Fund's Q4 performance and outlook for 2026. Read the full analysis of key winners ...

The Clinical Research Transformation: Future Outlook 2026 conference opened today, Monday, in Riyadh. Organized by King ...

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development ...